Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study

Authors
Publication date
1 January 2011
Publisher
'Ovid Technologies (Wolters Kluwer Health)'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Archivio istituzionale della Ricerca - Università degli Studi di Parma

      redirect
      oaioai:air.unipr.it:11381/2864787
      Last time updated on 29/10/2019